Symposium “Limiting of Infarct Size”
暂无分享,去创建一个
E. Braunwald | G. Schuler | R. Jennings | W. Kübler | F. Schwarz | K. Reimer | W. Bussmann | P. Spieckermann | W. Hort | H. Kalbfleisch | H. Frenzel | D. Röhrig | R. Maroko | A. Hjalmarson
[1] I. Wright,et al. Report of the Committee for the Evaluation of Anticoagulants in the Treatment of Coronary Thrombosis with Myocardial Infarction; a progress report on the statistical analysis of the first 800 cases studied by this committee. , 1948, American heart journal.
[2] H. Greisman,et al. Acute myocardial infarction: Detailed study of Dicumarol therapy in seventy-five consecutive cases , 1948 .
[3] A. Gilchrist,et al. Anticoagulants in Treatment of Coronary Thrombosis , 1950, British medical journal.
[4] Smith Fj,et al. Myocardial Infarction: A Study of the Acute Phase. , 1951 .
[5] H. Hultgren,et al. Experiences with dicumarol in acute myocardial infarction. , 1950, The New England journal of medicine.
[6] C. Holten. Anticoagulants in the treatment of coronary thrombosis. , 2009, Acta medica Scandinavica.
[7] R. Dutton,et al. A CLINICAL STUDY OF ANTICOAGULANTS IN ACUTE MYOCARDIAL INFARCTION WITH PARTICULAR REFERENCE TO EARLY HEPARIN THERAPY , 1957, The American journal of the medical sciences.
[8] T. Hilden,et al. ANTICOAGULANTS IN ACUTE MYOCARDIAL INFARCTION , 1961 .
[9] D. Sodi-Pallares,et al. The polarizing treatment of acute myocardial infarction. Possibility of its use in other cardiovascular conditions. , 1963, Diseases of the chest.
[10] R N SMITH,et al. Smog: 1962 v. 1952. , 1963, The Lancet.
[11] J. Sokal,et al. Controlled study of the treatment of coronary occlusion with urokinase-activated human plasmin , 1965 .
[12] P. Snow. Effect of propranolol in myocardial infarction. , 1965, Lancet.
[13] Jennings Rb,et al. FINE STRUCTURAL CHANGES IN MYOCARDIAL ISCHEMIC INJURY. , 1965 .
[14] A. Bisteni,et al. OXIDATIVE PHOSPHORYLATION IN CARDIAC INFARCT. EFFECT OF GLUCOSE-KCL-INSULIN SOLUTION. , 1965, The American journal of physiology.
[15] A. Wollenberger,et al. Anoxia-induced Release of Noradrenaline from the Isolated Perfused Heart , 1965, Nature.
[16] R. Balcon,et al. A controlled trial of propranolol in acute myocardial infarction. , 1966, Lancet.
[17] H. Poliwoda,et al. Zur thrombolytischen Therapie des frischen Herzinfarktes. II. Ergebnisse der elektrokardiographischen Untersuchungen* , 1966 .
[18] B. Nielsen,et al. Absence of prophylactic effect of propranolol in myocardial infarction. , 1966, Lancet.
[19] H. Poliwoda,et al. Zur thrombolytischen Therapie des frischen Herzinfarktes. I. Einführung, Behandlungspläne, allgemeine klinische Ergebnisse , 1966 .
[20] J. Williamson. Glycolytic control mechanisms. II. Kinetics of intermediate changes during the aerobic-anoxic transition in perfused rat heart. , 1966, The Journal of biological chemistry.
[21] J. van de Loo,et al. [On thrombolytic treatment of a recent heart infarction. 3. Comprehensive summary including enzyme evaluation]. , 1967, Deutsche medizinische Wochenschrift.
[22] D. Lübbers,et al. Oxygen transport in blood and tissue , 1968 .
[23] R. Bing,et al. Early Changes in Energy Metabolism in the Myocardium Following Acute Coronary Artery Occlusion in Anesthetized Dogs , 1968, Circulation research.
[24] S. Epstein,et al. An Evaluation of Fibrinolysin Therapy in Acute Myocardial Infarction , 1969, Angiology.
[25] A. Amery,et al. Single-blind randomised multicentre trial comparing heparin and streptokinase treatment in recent myocardial infarction. , 1969, Acta medica Scandinavica. Supplementum.
[26] W. Kübler,et al. Regulation of glycolysis in the ischemic and the anoxic myocardium. , 1970, Journal of molecular and cellular cardiology.
[27] V. A. Bradess,et al. Sudden death from coronary heart disease. Survival time, frequency of thrombi, and cigarette smoking. , 1970, Chest.
[28] J. Pantridge. Mobile coronary care. , 1970, Chest.
[29] R. Jennings. Myocardial ischemia--observations, definitions and speculations. , 1970, Journal of molecular and cellular cardiology.
[30] M. Verstraete. Streptokinase in Recent Myocardial Infarction: A Controlled Multicentre Trial , 1971, British medical journal.
[31] P. Mannucci,et al. Controlled trial of streptokinase and heparin in acute myocardial infarction. , 1971, Lancet.
[32] H. Mustaniemi,et al. Fibrinolytic treatment in acute myocardial infarction. , 2009, Acta medica Scandinavica.
[33] P. Libby,et al. Effect of Glucose‐Insulin‐Potassium Infusion on Myocardial Infarction following Experimental Coronary Artery Occlusion , 1972, Circulation.
[34] B. Sobel,et al. Estimation of Infarct Size in Man and its Relation to Prognosis , 1972, Circulation.
[35] J. Gormsen. BIOCHEMICAL EVALUATION OF STANDARD TREATMENT WITH STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION , 1972, Acta medica Scandinavica.
[36] J. J. Stark,et al. Improvement in myocardial function and coronary blood flow in ischemic myocardium after mannitol. , 1972, The Journal of clinical investigation.
[37] R. Ebert,et al. Anticoagulants in acute myocardial infarction: results of a cooperative clinical trial , 1973 .
[38] A. Carter. Letter: Pyridoxine contraindicated in parkinsonism. , 1973, Lancet.
[39] M. Rovetto,et al. Effects of ischemia on function and metabolism of the isolated working rat heart. , 1973, The American journal of physiology.
[40] P. Libby,et al. Reduction of experimental myocardial infarct size by corticosteroid administration. , 1973, The Journal of clinical investigation.
[41] J. Shillingford,et al. Prophylactic anticoagulant therapy in the prevention of calf-vein thrombosis after myocardial infarction. , 1973, The New England journal of medicine.
[42] J. Gormsen,et al. Biochemical evaluation of low dose of urokinase in acute myocardial infarction. A double-blind study. , 2009, Acta Medica Scandinavica.
[43] H. Kraft,et al. Die Kurzzeitfibrinolyse beim akuten Myokardinfarkt , 1973 .
[44] A. Leaf. Cell Swelling: A Factor in Ischemic Tissue Injury , 1973, Circulation.
[45] J. Hirsh,et al. Small Subcutaneous Doses of Heparin in Prevention of Venous Thrombosis , 1973 .
[46] J. van de Loo,et al. [Fibrinolytic therapy of acute myocardial infarct. II. German-Swiss common study. 2. Results of electrocardiographic studies]. , 1973, Zeitschrift fur Kardiologie.
[47] R. Jennings,et al. Effect of a transient period of ischemia on myocardial cells. I. Effects on cell volume regulation. , 1974, The American journal of pathology.
[48] Richard P. Lewis,et al. Factors determining mortality in the pre-hospital phase of acute myocardial infarction , 1974 .
[49] E. Braunwald,et al. Protection of hypoxic guinea pig hearts with glucose and insulin. , 1974, The American journal of physiology.
[50] R. Jennings,et al. Structural Changes in Myocardium During Acute Ischemia , 1974, Circulation research.
[51] A. Kaplan,et al. Interaction of leukocyte chemotactic factors with the cell surface. I. Chemotactic factor-induced changes in human granulocyte surface charge. , 1975, The Journal of clinical investigation.
[52] R. Jennings,et al. Ischemic tissue injury. , 1975, The American journal of pathology.
[53] H. Keen,et al. ORAL HYPOGLYCÆMICS IN DIABETES MELLITUS , 1975, The Lancet.
[54] C. Ansell. Letter: Milk for babies. , 1975, Lancet.
[55] B. Sobel. Quantification of myocardial ischemic injury. , 1975, Advances in cardiology.
[56] J. R. Miles,et al. Reduction of prehospital, ambulance and community coronary death rates by the community-wide emergency cardiac care system. , 1975, The American journal of medicine.
[57] J. Soothill,et al. Letter: Sudden-infant-death syndrome and immunodeficiency. , 1975, Lancet.
[58] L. Opie,et al. Effects of Glucose, Insulin and Potassium Infusion on Tissue Metabolic Changes Within First Hour of Myocardial Infarction in the Baboon , 1975, Circulation.
[59] S. Sherry,et al. Current status of antithrombotic therapy in cardiovascular disease. , 1976, Progress in cardiovascular diseases.
[60] W. J. Powell,et al. Effects of hyperosmotic mannitol in reducing ischemic cell swelling and minimizing myocardial necrosis. , 1976, Circulation.
[61] W. Rogers,et al. Glucose-insulin-potassium, free fatty acids and acute myocardial infarction in man. , 1976, Circulation.
[62] E. Raftery,et al. Streptokinase in acute myocardial infarction: a controlled multicentre study in the United Kingdom. , 1976, British medical journal.
[63] E. Craige,et al. On the genesis of heart sounds. Contributions made by echocardiographic studies. , 1976, Circulation.
[64] J. Hirsh,et al. Australian multicentre trial of streptokinase in acute myocardial infarction. , 1973, The Medical journal of Australia.
[65] J. Lowe,et al. Effect of the Calcium Antagonist Verapamil on Necrosis following Temporary Coronary Artery Occlusion in Dogs , 1977, Circulation.
[66] G. Hutchins,et al. Infarct expansion versus extension: two different complications of acute myocardial infarction. , 1978, The American journal of cardiology.
[67] D. Chamberlain,et al. The Brighton resuscitation ambulances: review of 40 consecutive survivors of out-of-hospital cardiac arrest. , 1978, British medical journal.
[68] K. Wildenthal. Lysosomal alterations in ischemic myocardium: result or cause of myocellular damage? , 1978, Journal of molecular and cellular cardiology.
[69] J. Hampton,et al. A RANDOMISED TRIAL OF HOME-VERSUS-HOSPITAL MANAGEMENT FOR PATIENTS WITH SUSPECTED MYOCARDIAL INFARCTION , 1978, The Lancet.
[70] P. Poole‐Wilson,et al. Hypoxia and calcium. , 1979, Journal of molecular and cellular cardiology.
[71] J. Farber,et al. Ischemic myocardial cell injury. Prevention by chlorpromazine of an accelerated phospholipid degradation and associated membrane dysfunction. , 1979, The American journal of pathology.
[72] R. Moulds. Propranolol in Acute Myocardial Infarction , 1979 .
[73] Reimer Ka,et al. The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. , 1979 .
[74] F. Witkowski,et al. Potential Arrhythmogenic Electrophysiological Derangements in Canine Purkinje Fibers Induced by Lysophosphoglycerides , 1979, Circulation research.
[75] K. Schechtman,et al. The Influence of Location and Extent of Myocardial Infarction on Long-term Ventricular Dysrhythmia and Mortality , 1979, Circulation.
[76] R. E. Clark,et al. Nifedipine: a myocardial protective agent. , 1979, The American journal of cardiology.
[77] F. Pedersen,et al. EFFECT OF ALPRENOLOL ON MORTALITY AMONG PATIENTS WITH DEFINITE OR SUSPECTED ACUTE MYOCARDIAL INFARCTION Preliminary Results , 1979, The Lancet.
[78] S. Glantz,et al. Quantitative Left Ventricular Wall Motion Analysis: A Comparison of Area, Chord Radial Methods , 1979, Circulation.
[79] N. Sammel,et al. Predictors of late hospital death in acute myocardial infarction. , 1980, Progress in cardiovascular diseases.
[80] R. Peto,et al. EARLY INTRAVENOUS ATENOLOL TREATMENT IN SUSPECTED ACUTE MYOCARDIAL INFARCTION Preliminary Report of a Randomised Trial , 1980, The Lancet.
[81] V. Rissanen. CORONARY ATHEROSCLEROSIS IN MIDDLE‐AGED AND ELDERLY FINNISH MEN. PATHOLOGICAL STUDY OF CORONARY ARTERIES IN VIOLENT AND SUDDEN CORONARY DEATHS , 1980, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.
[82] J. Williamson,et al. Effects of Nifedipine on Myocardial Perfusion and Ischemic Injury in Dogs , 1978, British journal of clinical practice. Supplement.
[83] M. Hori,et al. Site and severity of coronary narrowing and infarct size in man. , 1980, British heart journal.
[84] P. Rentrop,et al. [Intracoronary application of streptokinase in acute myocardial infarction and non-stable angina pectoris (author's transl)]. , 2008, Deutsche medizinische Wochenschrift.
[85] W. Seidel,et al. Reduction of CK and CK‐MB Indexes of Infarct Size by Intravenous Nitroglycerin , 1981, Circulation.
[86] P. Rentrop,et al. Selective Intracoronary Thrombolysis in Acute Myocardial Infarction and Unstable Angina Pectoris , 1981, Circulation.
[87] K. Swedberg,et al. EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION A Double-blind Randomised Trial , 1981, The Lancet.
[88] A. Adgey,et al. Arrhythmias in the first hours of acute myocardial infarction. , 1981, Progress in cardiovascular diseases.
[89] A. Schömig,et al. Catecholamines in Myocardial Hypoxia and Ischemia , 1981 .
[90] M. Verstraete,et al. Streptokinase in acute myocardial infarction , 1981 .
[91] R E Ideker,et al. Myocardial Infarct Size and Location in Relation to the Coronary Vascular Bed at Risk in Man , 1981, Circulation.
[92] W. Kübler,et al. Catecholamines and the Heart , 1981, Springer Berlin Heidelberg.
[93] W. Kübler,et al. Different Effects of Intracoronary and Intravenous Administration of Nitroglycerin on the Microcirculation of the Ventricular Myocardium of the Cat and Rat Heart , 1981 .
[94] R. Jennings,et al. Lethal myocardial ischemic injury. , 1981, The American journal of pathology.
[95] D. Feuvray,et al. Metabolic products and myocardial ischemia. , 1981, The American journal of pathology.
[96] P. Rentrop,et al. [Early and late changes of left ventricular function after non-surgical reperfusion (by intracoronary streptokinase infusion) in evolving myocardial infarction (author's transl)]. , 1982, Zeitschrift fur Kardiologie.
[97] R. Jennings,et al. Effect of hypothermia on changes in high-energy phosphate production and utilization in total ischemia. , 1982, Journal of molecular and cellular cardiology.